181 related articles for article (PubMed ID: 11068672)
1. A review of antimicrobial resistance in Canada.
Blondeau JM; Vaughan D
Can J Microbiol; 2000 Oct; 46(10):867-77. PubMed ID: 11068672
[TBL] [Abstract][Full Text] [Related]
2. The importance and future of antimicrobial surveillance studies.
Masterton R
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
[TBL] [Abstract][Full Text] [Related]
3. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
Fedler KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
[TBL] [Abstract][Full Text] [Related]
5. Current status and changing trends of antimicrobial resistance in Saudi Arabia.
Akhter J; Frayha HH; Qadri SM
J Med Liban; 2000; 48(4):227-32. PubMed ID: 11214194
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological factors influencing the emergence of antimicrobial resistance.
Cohen ML
Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
[TBL] [Abstract][Full Text] [Related]
8. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
Hoban DJ; Doern GV; Fluit AC; Roussel-Delvallez M; Jones RN
Clin Infect Dis; 2001 May; 32 Suppl 2():S81-93. PubMed ID: 11320449
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
Sahm DF; Brown NP; Thornsberry C; Jones ME
Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility testing and patterns of resistance at a tertiary care center.
Akhter J; Qutub MO; Qadri SM
Saudi Med J; 2001 Jul; 22(7):569-76. PubMed ID: 11479635
[TBL] [Abstract][Full Text] [Related]
11. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers.
Sader HS; Sampaio JL; Zoccoli C; Jones RN
Braz J Infect Dis; 1999 Apr; 3(2):63-79. PubMed ID: 11098193
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program.
Deshpande LM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Aug; 49(4):231-6. PubMed ID: 15313526
[TBL] [Abstract][Full Text] [Related]
13. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.
Thornsberry C; Sahm DF; Kelly LJ; Critchley IA; Jones ME; Evangelista AT; Karlowsky JA
Clin Infect Dis; 2002 Mar; 34 Suppl 1():S4-S16. PubMed ID: 11810606
[TBL] [Abstract][Full Text] [Related]
14. The Alexander Project: the benefits from a decade of surveillance.
Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
Mendes C; Kiffer CR; Blosser-Middleton RS; Jones ME; Karlowsky JA; Barth A; Rossi F; Andrade S; Sader HS; Thornsberry C; Sahm DF;
Clin Microbiol Infect; 2004 Jun; 10(6):521-6. PubMed ID: 15191379
[TBL] [Abstract][Full Text] [Related]
17. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
Doern GV
Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
[TBL] [Abstract][Full Text] [Related]
18. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
19. Common bacteria whose susceptibility to antimicrobials is no longer predictable.
Snyder JW; McDonald LC; Van Enk R
J Med Liban; 2000; 48(4):208-14. PubMed ID: 11214191
[TBL] [Abstract][Full Text] [Related]
20. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
